Serum Institute Of India English news | Serum Institute Of India, Latest News & Live Updates in English | English News (Latest English News) at Lokmattimes.com

India should prepare to give one crore COVID-19 jabs a day which will be possible in a few weeks with due preparation and the vaccination should be taken up to 73 doses in the next three weeks, Niti Aayog Member (Health) Dr VK Paul has said.Dr Paul, who also heads the National Expert Group on Vaccine Administration for COVID-19 (NEGVAC),toldin an interview that the mismatch between the demand and supply of COVID-19 vaccines is universal and the country is ramping up its production of doses."We'll have to prepare to give one crore doses in a day. It will be possible in few weeks, we will have to prepare. We made possible 43 lakh doses in a day. We should bring it up to 73 lakh in next three weeks. We should make a system to achieve it," he told ANI.He said vaccination policy was liberalized on the demand of states."States know our vaccine production capacity. When they said they want flexibility and say in vaccine procurement, a new system was brought in under which Centre will procure 50 per cent of vaccines produced domestically for states for free, for 45+ group," he said."Besides this, a special channel was created for remaining 50 per cent where state governments and private sector can purchase and supply vaccines. On whatever states procure, (from private sector) states have to decide as to which group it has to be given to and taken forward."To say that the supply has closed isn't true. Truth is that out of the available production, a distinct part is available to non-govt channels, including state govts, to be used for vaccinating people of their state according to flexible approach by state government," he added.He said total capacity to produce COVID vaccines across the world is much less than the requirements"The mismatch between the supply and demand of vaccine is universal. We are in a phase when vaccine supplies are ramping up but they are still not matching the total requirement of the eligible population," he said.Noting that India is a major hub of vaccine production, he said the government has been working with COVID vaccine companies to increase the production in the country.Referring to vaccination of children, he said Covaxin has received permission and they will start the paediatric trial."I think they are going all the way to two years of age in a systematic way. I have been told that Serum Institute of India wants to begin the paediatric trial of Novavax," he said.Dr Paul said it has been found out now that Pfizer can be administered to the younger population and one-two countries will start doing it now."When any drug/vaccine is discovered, typically it is first sorted out in the adult population because you do not want to risk children....It has been found out now that Pfizer can be administered to the younger population," he said."One-two countries will start doing that now. WHO hasn't given any recommendation yet to cover pediatric population in general as any illness in pediatric population is very very mild. If we go with paradigm of deaths as a public health objective," he added.( With inputs from ANI )Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Serum Institute Of IndiaFOLLOW

Serum institute of india, Latest News

Amid discussions over possible legal protection to foreign vaccine manufacturers Pfizer and Moderna over their COVID-19 jabs in India, the Serum Institute of India (SII) has also sought protection against liabilities, sources said on Thursday. ...

Serum Institute of India (SII), the company producing the AstraZeneca Covishield vaccine has sought legal protection from any claims ... ...

Adar Poonawalla of the Serum Institute of Pune is serving the country by providing vaccines to the country for ... ...

A man in Uttar Pradesh's Lucknow has filed a complaint against Serum Institute of India (SII) CEO Adar Poonawala and Dr. Balram Bhargava, head of the Indian Council of Medical Research (ICMR) after he alleged that no antibodies were formed in his bod ...

A Lucknow-based trader has filed an FIR against the Serum Institute of India (SII), which manufactures the Covishield vaccine, ... ...

The Government of India targets to procure 20 to 25 crore COVID-19 vaccine doses by July-end and 30 crore doses in August-September, informed government sources on Sunday. ...

The Government of India targets to procure 20 to 25 crore COVID-19 vaccine doses by July-end and 30 crore doses in August-September, informed government sources on Sunday. ...

India should prepare to give one crore COVID-19 jabs a day which will be possible in a few weeks with due preparation and the vaccination should be taken up to 73 doses in the next three weeks, Niti Aayog Member (Health) Dr VK Paul has said. ...